153 related articles for article (PubMed ID: 35690746)
1. One-year follow-up healthcare costs of patients diagnosed with skin cancer in Germany: a claims data analysis.
Speckemeier C; Pahmeier K; Trocchi P; Schuldt K; Lax H; Nonnemacher M; Dröge P; Stang A; Wasem J; Neusser S
BMC Health Serv Res; 2022 Jun; 22(1):771. PubMed ID: 35690746
[TBL] [Abstract][Full Text] [Related]
2. Costs of routine skin cancer screening in Germany: a claims data analysis.
Krensel M; Andrees V; Mohr N; Hischke S
Clin Exp Dermatol; 2021 Jul; 46(5):842-850. PubMed ID: 33378094
[TBL] [Abstract][Full Text] [Related]
3. Nationwide hospitalization costs of skin melanoma and non-melanoma skin cancer in Germany.
Stang A; Stausberg J; Boedeker W; Kerek-Bodden H; Jöckel KH
J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):65-72. PubMed ID: 18181975
[TBL] [Abstract][Full Text] [Related]
4. The many unanswered questions related to the German skin cancer screening programme.
Stang A; Garbe C; Autier P; Jöckel KH
Eur J Cancer; 2016 Sep; 64():83-8. PubMed ID: 27371911
[TBL] [Abstract][Full Text] [Related]
5. Estimating the health care costs of non-melanoma skin cancer in Saskatchewan using physician billing data.
Tran DA; Coronado AC; Sarker S; Alvi R
Curr Oncol; 2019 Apr; 26(2):114-118. PubMed ID: 31043813
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology of skin cancer in the German population: impact of socioeconomic and geographic factors.
Augustin J; Kis A; Sorbe C; Schäfer I; Augustin M
J Eur Acad Dermatol Venereol; 2018 Nov; 32(11):1906-1913. PubMed ID: 29633375
[TBL] [Abstract][Full Text] [Related]
7. Estimating prevalence and incidence of skin cancer in Germany.
Krensel M; Petersen J; Mohr P; Weishaupt C; Augustin J; Schäfer I
J Dtsch Dermatol Ges; 2019 Dec; 17(12):1239-1249. PubMed ID: 31885171
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of skin cancer screening for individuals age 14 to 34 years.
Schmitt J; Seidler A; Heinisch G; Sebastian G
J Dtsch Dermatol Ges; 2011 Aug; 9(8):608-16. PubMed ID: 21501381
[TBL] [Abstract][Full Text] [Related]
9. Skin Cancer Screening and Medical Treatment Intensity in Patients with Malignant Melanoma and Non-Melanocytic Skin Cancer.
Schuldt K; Trocchi P; Stang A
Dtsch Arztebl Int; 2023 Jan; 120(3):33-39. PubMed ID: 36471642
[TBL] [Abstract][Full Text] [Related]
10. The impossibility of mortality evaluation of skin cancer screening in Germany based on health insurance data: a case-control study.
Stang A; Schuldt K; Trocchi P; Neusser S; Speckemeier C; Pahmeier K; Wasem J; Lax H; Nonnemacher M
Eur J Cancer; 2022 Sep; 173():52-58. PubMed ID: 35863106
[TBL] [Abstract][Full Text] [Related]
11. Effects of the German skin cancer screening programme on melanoma incidence and indicators of disease severity.
Trautmann F; Meier F; Seidler A; Schmitt J
Br J Dermatol; 2016 Nov; 175(5):912-919. PubMed ID: 27203791
[TBL] [Abstract][Full Text] [Related]
12. Development of a microsimulation of melanoma mortality for evaluating the effectiveness of population-based skin cancer screening.
Eisemann N; Waldmann A; Garbe C; Katalinic A
Med Decis Making; 2015 Feb; 35(2):243-54. PubMed ID: 25145574
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology of cutaneous melanoma and non-melanoma skin cancer in Schleswig-Holstein, Germany: incidence, clinical subtypes, tumour stages and localization (epidemiology of skin cancer).
Katalinic A; Kunze U; Schäfer T
Br J Dermatol; 2003 Dec; 149(6):1200-6. PubMed ID: 14674897
[TBL] [Abstract][Full Text] [Related]
14. Ankylosing spondylitis causes high burden to patients and the healthcare system: results from a German claims database analysis.
Krüger K; von Hinüber U; Meier F; Tian H; Böhm K; Jugl SM; Borchert K; Meise D; König C; Braun S
Rheumatol Int; 2018 Nov; 38(11):2121-2131. PubMed ID: 30094685
[TBL] [Abstract][Full Text] [Related]
15. Opportunities to inform German residents about the possibility of skin cancer screening and to inform stakeholders to take appropriate actions: A qualitative approach.
Steeb T; Wessely A; Heppt MV; Erdmann M; Klug SJ; Berking C
Cancer Med; 2023 May; 12(9):10829-10839. PubMed ID: 37062065
[TBL] [Abstract][Full Text] [Related]
16. Non-melanoma skin cancer in Australia.
Fransen M; Karahalios A; Sharma N; English DR; Giles GG; Sinclair RD
Med J Aust; 2012 Nov; 197(10):565-8. PubMed ID: 23163687
[TBL] [Abstract][Full Text] [Related]
17. Health economic evaluation of non-melanoma skin cancer and actinic keratosis.
Higashi MK; Veenstra DL; Langley PC
Pharmacoeconomics; 2004; 22(2):83-94. PubMed ID: 14731050
[TBL] [Abstract][Full Text] [Related]
18. Routine skin cancer screening in Germany: First data on the impact on health care in dermatology.
Augustin M; Blome C; Rustenbach SJ; Reusch M; Radtke M
J Dtsch Dermatol Ges; 2010 Sep; 8(9):674-80. PubMed ID: 20529170
[TBL] [Abstract][Full Text] [Related]
19. Risk of skin cancer in patients on chronic haemodialysis: a nationwide, population-based study in Taiwan.
Wang CC; Tang CH; Wang CY; Huang SY; Sue YM
Br J Dermatol; 2016 Dec; 175(6):1175-1182. PubMed ID: 27273242
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
